The MEA sepsis diagnostics market is expected to grow from US$ 19.20 million in 2021 to US$ 33.35 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028.

Technology is a critical parameter in healthcare diagnostics to provide accuracy and save time and resources. In the process of sepsis diagnosis, identification of the causative pathogen is essential in selecting appropriate antibiotic therapy as part of the treatment. Molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology are majorly used sepsis diagnostics techniques. Among all, molecular diagnostics (MDx) is an attractive approach to consider for sepsis diagnostics. The increasing adoption of molecular diagnostic technology due to its several advantages, such as high sensitivity, accuracy, and less turnaround time, over other technologies has proved it the gold standard. Therefore, several companies are investing in point-of-care molecular diagnostics to diagnose bacterial and viral pathogens early and for better patient management. This test is one of the first rapid, fully integrated, and immune response-based tests to aid clinicians with a sepsis diagnosis. Thus, the rising use of technology, such as molecular diagnostics, in sepsis diagnosis is a crucial trend followed by emerging key players operating in the market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA sepsis diagnostics market. The MEA sepsis diagnostics market is expected to grow at a good CAGR during the forecast period.

MEA Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

MEA Sepsis Diagnostics Market Segmentation

The MEA sepsis diagnostics market is segmented based on product, technology, method, test type, pathogen, end user, and country. Based on product, the MEA sepsis diagnostics market is divided into instruments, reagents and assays, blood culture media, and software. The blood culture media dominated the MEA sepsis diagnostics market in 2021. Based on technology, the MEA sepsis diagnostics market is categorized into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment dominated the MEA sepsis diagnostics market in 2021. Based on method, the MEA sepsis diagnostics market is categorized into automated diagnostics and conventional diagnostics. The conventional diagnostics segment dominated the MEA sepsis diagnostics market in 2021. Based on test type, the MEA sepsis diagnostics market is categorized into point-of-care tests and laboratory tests. The laboratory tests segment dominated the MEA sepsis diagnostics market in 2021. Based on pathogen, the MEA sepsis diagnostics market is categorized into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment dominated the MEA sepsis diagnostics market in 2021. Based on end user, the MEA sepsis diagnostics market is categorized into hospitals, pathology and reference laboratories, and others. The hospitals segment dominated the MEA sepsis diagnostics market in 2021. Based on country, the MEA sepsis diagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Saudi Arabia dominated the MEA sepsis diagnostics market in 2021.

Key players operating in the MEA sepsis diagnostics market include Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; BD; Danaher (Beckman Coulter); Luminex Corporation; THERMO FISHER SCIENTIFIC INC.; bioMerieux SA; and T2 Biosystems, Inc. by Altair.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Sepsis Diagnostics Market – By Product
1.3.2 MEA Sepsis Diagnostics Market – By Technology
1.3.3 MEA Sepsis Diagnostics Market – By Method
1.3.4 MEA Sepsis Diagnostics Market – By Test Type
1.3.5 MEA Sepsis Diagnostics Market – By Pathogen
1.3.6 MEA Sepsis Diagnostics Market – By End User
1.3.7 MEA Sepsis Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Sepsis Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Sepsis Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Large Incidence of Sepsis due to Increasing Nosocomial Infections
5.1.2 High in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
5.2.1 Shortage of Skilled Professionals
5.3 Market Opportunities
5.3.1 Funding Increase and Support for Sepsis Diagnostics Research
5.4 Future Trends
5.4.1 Increasing Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis
6. Sepsis Diagnostics Market– MEA Analysis
6.1 MEA Sepsis Diagnostics Market Revenue Forecast and Analysis
7. MEA Sepsis Diagnostics Market – By Product
7.1 Overview
7.2 MEA Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
7.4.1 Overview
7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
7.5.1 Overview
7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. MEA Sepsis Diagnostics Market – By Technology
8.1 Overview
8.2 MEA Sepsis Diagnostics Market Share by Technology – 2021 & 2028 (%)
8.3 Molecular Diagnostics
8.3.1 Overview
8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Polymerase Chain Reaction
8.3.2.1.1 Overview
8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
8.3.2.2.1 Overview
8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Syndromic Panel-Based Testing
8.3.2.3.1 Overview
8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Microarrays
8.3.2.4.1 Overview
8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
8.4.1 Overview
8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
8.5.1 Overview
8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
8.6.1 Overview
8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
8.7.1 Overview
8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
8.8.1 Overview
8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. MEA Sepsis Diagnostics Market – By Method
9.1 Overview
9.2 MEA Sepsis Diagnostics Market Share by Method – 2021 & 2028 (%)
9.3 Automated Diagnostics
9.3.1 Overview
9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
9.4.1 Overview
9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. MEA Sepsis Diagnostics Market – By Test Type
10.1 Overview
10.2 MEA Sepsis Diagnostics Market Share by Test Type – 2021 & 2028 (%)
10.3 Point-of-Care Tests
10.3.1 Overview
10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
10.4.1 Overview
10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11. MEA Sepsis Diagnostics Market – By Pathogen
11.1 Overview
11.2 MEA Sepsis Diagnostics Market Share by Pathogen – 2021 & 2028 (%)
11.3 Bacterial Sepsis
11.3.1 Overview
11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
11.4.1 Overview
11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12. MEA Sepsis Diagnostics Market – By End User
12.1 Overview
12.2 MEA Sepsis Diagnostics Market Share by End User – 2021 & 2028 (%)
12.3 Hospitals
12.3.1 Overview
12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
12.4.1 Overview
12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
12.5.1 Overview
12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
13. MEA Sepsis Diagnostics Market Revenue and Forecasts to 2028 – By Country Analysis
13.1 MEA: Sepsis Diagnostics Market Revenue and Forecasts To 2028
13.1.1 Overview
13.1.2 MEA: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
13.1.2.1 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.1.1 Overview
13.1.2.1.2 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.1.3 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.2.1.4 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.1.4.1 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.1.5 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.1.6 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.1.7 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.1.8 UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.1.2.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.2.1 Overview
13.1.2.2.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.2.3 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.2.2.4 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.2.4.1 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.2.5 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.2.6 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.2.7 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.2.8 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.1.2.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.3.1 Overview
13.1.2.3.2 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.3.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.2.3.4 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.3.4.1 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.3.5 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.3.6 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.3.7 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.3.8 South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.1.2.4 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.4.1 Overview
13.1.2.4.2 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.4.3 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.2.4.4 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.4.4.1 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.4.5 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.4.6 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.4.7 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.4.8 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
14. Sepsis Diagnostics Market–Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. Company Profiles
15.1 Abbott
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. HOFFMANN-LA ROCHE LTD.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Immunexpress Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 BD
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Danaher (Beckman Coulter)
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Luminex Corporation
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 THERMO FISHER SCIENTIFIC INC.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 bioMerieux SA
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 T2 Biosystems, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms

LIST OF TABLES

Table 1.             UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 2.             UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 3.             UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 4.             UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 5.             UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 6.             UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 7.             UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 8.             Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 9.             Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 10.          Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 11.          Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 12.          Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 13.          Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 14.          Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 15.          South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 16.          South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 17.          South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 18.          South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 19.          South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 20.          South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 21.          South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 22.          Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 23.          Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 24.          Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 25.          Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 26.          Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 27.          Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 28.          Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 29.          Organic Developments in the Sepsis Diagnostics Market
Table 30.          Inorganic Developments in the Sepsis Diagnostics Market
Table 31.          Glossary of Terms
 
 

LIST OF FIGURES

Figure 1.           MEA Sepsis Diagnostics Market Segmentation
Figure 2.           MEA Sepsis Diagnostics Market, By Country
Figure 3.           MEA Sepsis Diagnostics Market Overview
Figure 4.           Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market
Figure 5.           Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
Figure 6.           MEA: PEST Analysis
Figure 7.           MEA Experts Opinion
Figure 8.           MEA Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9.           MEA Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10.        MEA Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
Figure 11.        MEA Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12.        MEA Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13.        MEA Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14.        MEA Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15.        MEA Sepsis Diagnostics Market Share by Technology – 2021 & 2028 (%)
Figure 16.        MEA Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17.        MEA Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18.        MEA Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19.        MEA Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20.        MEA Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21.        MEA Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22.        MEA Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23.        MEA Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24.        MEA Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25.        MEA Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26.        MEA Sepsis Diagnostics Market Share by Method – 2021 & 2028 (%)
Figure 27.        MEA Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28.        MEA Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29.        MEA Sepsis Diagnostics Market Share by Test Type – 2021 & 2028 (%)
Figure 30.        MEA Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31.        MEA Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32.        MEA Sepsis Diagnostics Market Share by Pathogen – 2021 & 2028 (%)
Figure 33.        MEA Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34.        MEA Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35.        MEA Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36.        MEA Sepsis Diagnostics Market Share by End User – 2021 & 2028 (%)
Figure 37.        MEA Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38.        MEA Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 39.        MEA Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40.        MEA: Sepsis Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 41.        MEA Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
Figure 42.        UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 43.        Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 44.        South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 45.        Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 46.        Growth Strategies in the Sepsis Diagnostics Market (%)
 
 

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA sepsis diagnostics market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the MEA sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the MEA sepsis diagnostics market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – Middle East & Africa Sepsis Diagnostics Market

● Abbott
● F. HOFFMANN-LA ROCHE LTD.
● Immunexpress Inc.
● BD
● Danaher (Beckman Coulter)
● Luminex Corporation
● THERMO FISHER SCIENTIFIC INC.
● bioMerieux SA
● T2 Biosystems, Inc
●